- Home
- AKAM vs PCVX Comparison
AKAM vs PCVX Comparison
Compare AKAM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKAM
- PCVX
- Stock Information
- Founded
- AKAM 1998
- PCVX 2013
- Country
- AKAM United States
- PCVX United States
- Employees
- AKAM N/A
- PCVX N/A
- Industry
- AKAM Business Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- AKAM Consumer Discretionary
- PCVX Health Care
- Exchange
- AKAM Nasdaq
- PCVX Nasdaq
- Market Cap
- AKAM 14.7B
- PCVX 13.2B
- IPO Year
- AKAM 1999
- PCVX 2020
- Fundamental
- Price
- AKAM $94.12
- PCVX $85.75
- Analyst Decision
- AKAM Buy
- PCVX Strong Buy
- Analyst Count
- AKAM 20
- PCVX 7
- Target Price
- AKAM $115.79
- PCVX $147.50
- AVG Volume (30 Days)
- AKAM 1.7M
- PCVX 1.0M
- Earning Date
- AKAM 02-11-2025
- PCVX 11-05-2024
- Dividend Yield
- AKAM N/A
- PCVX N/A
- EPS Growth
- AKAM 2.15
- PCVX N/A
- EPS
- AKAM 3.38
- PCVX N/A
- Revenue
- AKAM $3,966,246,000.00
- PCVX N/A
- Revenue This Year
- AKAM $6.51
- PCVX N/A
- Revenue Next Year
- AKAM $6.26
- PCVX N/A
- P/E Ratio
- AKAM $27.84
- PCVX N/A
- Revenue Growth
- AKAM 5.92
- PCVX N/A
- 52 Week Low
- AKAM $84.70
- PCVX $53.83
- 52 Week High
- AKAM $129.17
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- AKAM 42.40
- PCVX 35.99
- Support Level
- AKAM $97.68
- PCVX $86.80
- Resistance Level
- AKAM $100.39
- PCVX $92.94
- Average True Range (ATR)
- AKAM 1.98
- PCVX 3.53
- MACD
- AKAM 0.05
- PCVX 0.20
- Stochastic Oscillator
- AKAM 6.56
- PCVX 7.21
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.